Medications for Treating Cocaine Use Disorder
Currently, there are no FDA-approved medications specifically for cocaine use disorder, but contingency management plus community reinforcement approach is the most effective treatment combination for improving morbidity, mortality, and quality of life outcomes. 1
Psychosocial Interventions (First-Line Treatment)
- Contingency Management (CM) plus Community Reinforcement Approach (CRA) is the most effective treatment combination, with only 4 patients needing treatment to have 1 additional patient achieve abstinence compared to treatment as usual 2, 1
- Contingency Management (CM) alone or combined with Cognitive Behavioral Therapy (CBT) shows superior efficacy compared to treatment as usual 2, 1
- CBT alone is recommended as an alternative when CM+CRA is not available, though it shows less efficacy 1
Pharmacological Options (Adjunctive Treatments)
Medications with Some Evidence of Efficacy:
Psychostimulants: May improve cocaine abstinence (RR 1.36,95% CI 1.05 to 1.77) though evidence quality is very low 3
Bupropion: May increase abstinence rates (RR 1.63,95% CI 1.02 to 2.59) with low strength of evidence 4
- However, some studies show no significant difference between bupropion and placebo when combined with CBT 5
Topiramate: May improve abstinence (RR 2.56,95% CI 1.39 to 4.73) with low strength of evidence 4
Varenicline: Shows potential for decreasing cocaine use and reward in preliminary studies 6
Medications for Specific Symptoms:
For cocaine craving: Clonidine, mirtazapine, and progesterone have shown some promise in reducing cravings 7
For co-occurring mental health conditions: Antipsychotics may improve treatment retention (RR 1.33,95% CI 1.03 to 1.75) with moderate strength of evidence 4
Management of Acute Cocaine-Related Complications
- For cocaine-associated chest pain:
- Benzodiazepines are first-line treatment 2
- Nitroglycerin can relieve cocaine-associated chest pain and reverse cocaine-associated vasoconstriction 2
- Avoid beta-blockers as they can worsen coronary vasoconstriction 2, 1
- Calcium channel blockers should not be used as first-line treatment but may be considered for patients who don't respond to benzodiazepines and nitroglycerin 2
Comprehensive Treatment Approach
- Integrate substance use disorder screening into routine care, particularly for high-risk populations 1, 8
- Assess for medical complications of stimulant use, particularly cardiovascular issues 1
- Provide harm reduction services including naloxone dispensation, safe use education, and referral to syringe services 1, 8
- For patients with co-occurring opioid and stimulant use disorders, medications for opioid use disorder should be initiated without delay 1
Common Pitfalls to Avoid
- Relying solely on drug testing without clinical context can lead to misdiagnosis 1
- Using selective β1-blockers in patients who may continue to use cocaine can lead to unopposed α-adrenergic stimulation 1
- Failing to recognize that stimulant use disorders frequently co-occur with other substance use and mental health disorders 1, 8
- Focusing solely on abstinence rather than harm reduction approaches 8